📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Passage Bio

1.1 - Company Overview

Passage Bio Logo

Passage Bio

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of fully integrated gene therapy development focused on treatments for monogenic central nervous system diseases.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Passage Bio

Epimeron Logo

Epimeron

HQ: United States Website
  • Description: Provider of gene discovery, deployment, and optimization solutions that support important plant biochemical functions required for maximum product yield.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Epimeron company profile →
Tavotek Biotherapeutics Logo

Tavotek Biotherapeutics

HQ: United States Website
  • Description: Provider of therapeutic medicine discovery, development and commercialization, with platforms and programs including TavoSelect phage display to discover diversified human antibody sequences for biologics and diagnostics; TavoPrecise to develop optimized mono- and multi-specific biologics; TavoELITE to address intracellular undruggable targets; and oncology and immunology therapeutics for cancer, inflammatory and allergic diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tavotek Biotherapeutics company profile →
QuantRx Biomedical Logo

QuantRx Biomedical

HQ: United States Website
  • Description: Provider of diagnostic products for the healthcare industry, focusing on their development and commercialization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full QuantRx Biomedical company profile →
Microsynbiotix Logo

Microsynbiotix

HQ: Ireland Website
  • Description: Provider of technology to eliminate excessive antibiotic use in farmed fish by engineering microalgae, leveraging advances in algal genomics and molecular biology to express inexpensive therapeutic proteins and vaccines of economic value.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Microsynbiotix company profile →
Touchlight Logo

Touchlight

HQ: United Kingdom Website
  • Description: Provider of a DNA production platform and services for developing DNA vaccines in oncology and infectious diseases. Offers dbDNA synthetic DNA vector technology with enzymatic manufacturing for high-speed, scalable, high-purity DNA; contract manufacturing including GMP dbDNA for advanced therapy medicinal product manufacture; pre-clinical, development, and regulatory support.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Touchlight company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Passage Bio

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Passage Bio

2.2 - Growth funds investing in similar companies to Passage Bio

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Passage Bio

4.2 - Public trading comparable groups for Passage Bio

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Passage Bio

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Passage Bio

What does Passage Bio do?

Passage Bio is a provider of fully integrated gene therapy development focused on treatments for monogenic central nervous system diseases.

Who are Passage Bio's competitors?

Passage Bio's competitors and similar companies include Epimeron, Tavotek Biotherapeutics, QuantRx Biomedical, Microsynbiotix, and Touchlight.

Where is Passage Bio headquartered?

Passage Bio is headquartered in United States.

How many employees does Passage Bio have?

Passage Bio has 1,000 employees 🔒.

When was Passage Bio founded?

Passage Bio was founded in 2010 🔒.

What sector and industry vertical is Passage Bio in?

Passage Bio is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Passage Bio

Who are the top strategic acquirers in Passage Bio's sector and industry

Top strategic M&A buyers and acquirers in Passage Bio's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Passage Bio?

Top strategic M&A buyers groups and sectors for Passage Bio include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Passage Bio's sector and industry vertical

Which are the top PE firms investing in Passage Bio's sector and industry vertical?

Top PE firms investing in Passage Bio's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Passage Bio's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Passage Bio's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Passage Bio's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Passage Bio include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Passage Bio's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Passage Bio?

The key public trading comparables and valuation benchmarks for Passage Bio include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Passage Bio for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Passage Bio with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Passage Bio's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Passage Bio with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Passage Bio's' sector and industry vertical?

Access recent funding rounds and capital raises in Passage Bio's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Passage Bio

Launch login modal Launch register modal